VEGFA and neoplasm: However, the underlying mechanisms are poorly understood.<h4>Methods</h4>Tumor-bearing mice were subjected to chronic restraint stress and treated with normal saline, human monoclonal VEGF-A neutralizing antibody bevacizumab, or β-adrenergic receptor (β-AR) antagonist (propranolol).